ADAPTIMMUNE THERAPEUTICS PLC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by ADAPTIMMUNE THERAPEUTICS PLC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2017-02-03Laing Ian MichaelAdaptimmune Therapeutics PLC29,346,6756.9%EDGAR
SC 13G/A2017-02-03Cross Nicholas JohnAdaptimmune Therapeutics PLC29,322,1786.9%EDGAR
SC 13G/A2017-02-03Robinson George Edward SilvanusAdaptimmune Therapeutics PLC22,896,5205.4%EDGAR
SC 13G2016-04-13Immunocore LtdAdaptimmune Therapeutics PLC26,976,7006.4%EDGAR
SC 13G2016-03-25Robinson George Edward SilvanusAdaptimmune Therapeutics PLC29,942,8007.0%EDGAR
SC 13G2016-03-25Laing Ian MichaelAdaptimmune Therapeutics PLC29,202,6756.9%EDGAR
SC 13G2016-03-25Cross Nicholas JohnAdaptimmune Therapeutics PLC29,042,8006.8%EDGAR
SC 13G/A2016-02-12FMR LLCAdaptimmune Therapeutics PLC39,553,8109.3%EDGAR
SC 13G2016-02-12Capital World InvestorsAdaptimmune Therapeutics PLC27,606,0006.5%EDGAR
SC 13G2016-02-10New Enterprise Associates 14, L.P.Adaptimmune Therapeutics PLC59,269,00014.0%EDGAR
SC 13D/A2015-11-19ORBIMED ADVISORS LLCAdaptimmune Therapeutics PLC28,041,0046.6%EDGAR
SC 13D2015-05-15ORBIMED ADVISORS LLCAdaptimmune Therapeutics PLC26,467,1206.2%EDGAR
SC 13G2015-05-11FMR LLCAdaptimmune Therapeutics PLC24,880,3186.0%EDGAR
External links